Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rapid Micro Biosystems (RPID) Other Operating Expenses (2020 - 2025)

Rapid Micro Biosystems (RPID) has disclosed Other Operating Expenses for 6 consecutive years, with $14.9 million as the latest value for Q4 2025.

  • Quarterly Other Operating Expenses rose 46.12% to $14.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $44.6 million through Dec 2025, up 7.71% year-over-year, with the annual reading at $44.6 million for FY2025, 7.71% up from the prior year.
  • Other Operating Expenses hit $14.9 million in Q4 2025 for Rapid Micro Biosystems, up from $10.0 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $14.9 million in Q4 2025 to a low of $8.6 million in Q2 2022.
  • Historically, Other Operating Expenses has averaged $10.5 million across 5 years, with a median of $10.3 million in 2023.
  • Biggest five-year swings in Other Operating Expenses: surged 103.58% in 2021 and later decreased 22.35% in 2022.
  • Year by year, Other Operating Expenses stood at $11.1 million in 2021, then fell by 0.45% to $11.1 million in 2022, then dropped by 12.88% to $9.7 million in 2023, then grew by 5.68% to $10.2 million in 2024, then skyrocketed by 46.12% to $14.9 million in 2025.
  • Business Quant data shows Other Operating Expenses for RPID at $14.9 million in Q4 2025, $10.0 million in Q3 2025, and $10.1 million in Q2 2025.